Skip to content
Disclosery

EXANE DERIVATIVES: CNH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CNH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 121 CNH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 121 shares
    Change vs previous 13F -30,014 shares

    <0.01% of the 13F portfolio, value $1,655.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 30,135 shares
    Change vs previous 13F -687,256 shares

    0.13% of the 13F portfolio, value $477,439.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 717,391 shares
    Change vs previous 13F +659,094 shares

    2.77% of the 13F portfolio, value $11,399,179.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 58,297 shares
    Change vs previous 13F -173,707 shares

    0.24% of the 13F portfolio, value $952,969.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 232,004 shares
    Change vs previous 13F +207,476 shares

    0.9% of the 13F portfolio, value $3,820,182.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 24,528 shares
    Change vs previous 13F +21,504 shares

    0.11% of the 13F portfolio, value $379,517.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,024 shares
    Change vs previous 13F -8,630 shares

    0.01% of the 13F portfolio, value $38,318.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 11,654 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $90,714.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).